Left ventricular assist devices (LVAD) are increasingly common across the heart failure
population. Right ventricular failure (RVF) is a feared complication that can occur in the early …

(1) Background: Acute kidney injury (AKI) is related to adverse outcomes in critical illness
and cardiovascular surgery. In this study, a systematic literature review and meta-analysis …

Cardiac surgery-associated AKI (CSA-AKI) is common after cardiac surgery and has an
adverse impact on short-and long-term mortality. Early identification of patients at high risk of …

Durable and temporary mechanical circulatory support (MCS) use is growing for a range of
cardiovascular indications. Kidney dysfunction is common in people evaluated for or …

Patients with the recovery of kidney function after an episode of acute kidney injury (AKI)
have better outcomes compared to those without recovery. The current systematic review is …

LVAD therapy is an effective rescue in acute and especially chronic cardiac failure. In
several scenarios, it provides a platform for regeneration and sustained myocardial …

Renal replacement therapy (RRT) after continuous flow left ventricular assist device (CF-
LVAD) implantation significantly affects patients' quality of life and survival. To identify …

Background In patients requiring mechanical circulatory support (MCS), the incidence of
acute kidney injury (AKI) is between 37 and 63%. In this study, we performed an exploratory …

The use of continuous‐flow ventricular assist devices (cf‐VAD) necessitates systemic
anticoagulation, routinely with vitamin K antagonists (VKA). Newer direct oral anticoagulants …

Heart failure (HF) is an irreversible disease characterized by the reducing capacity of blood
supply as a consequence of cardiomyocyte death and deteriorated fibrosis. There is a lack …